Navigation Links
Medspira and Mayo Clinic Enter Into Agreement
Date:11/18/2009

MINNEAPOLIS, Nov. 18 /PRNewswire/ -- Medspira, and Mayo Clinic have entered into an agreement to commercialize, manufacture and market several Mayo Clinic developed products and technologies invented by Mayo physicians and scientists. Mayo Clinic technologies included in the license agreement are two Radiology products currently available in the market, the Interactive Breath-Hold Control System and the BC-10 MRI Coils, and two technologies that Medspira will develop further, with the intent of making them commercially available in the next 12-24 months. "Medspira is honored to work with Mayo Clinic where research is a critical part of its commitment to excellence and interdependence in the three areas of research, education and patient care," said Tim Anderson Medspira CEO.

Commercially Available Technologies

The Breath Hold Interactive Breath-Hold Control System is a noninvasive device that enables patients to perform consistent, repeatable breath-holds during diagnostic imaging and image-guided interventional procedures. Respiratory motion and inconsistent patient breath-holds can prevent accurate needle biopsies of small masses in the lung and upper abdomen. Image-guided needle biopsies can be preformed on an outpatient basis, have less complications, are much less invasive to the patient, and are less costly than surgical biopsies. Breath Hold has FDA cleared (Class II, 513(g)) and CE marked (Class I).

Mayo Clinic's BC-10 MRI Coil is designed to allow acquisition of high resolution MRI images of the wrist at 1.5 and 3.0 Tesla. The BC-10's bird cage design provides a level of detail needed to diagnose many problems within the complicated structures of the wrist and hand. Products have FDA cleared (510(k) Class II) and CE marked (Class I).

Technologies Under Development:

New technologies for diagnosis and treatment of fecal incontinence (FI) will help primary care providers, gastroenterologists, colorectal surgeons, and gynecologists care for patients with FI. FI is most common in the elderly and in women after childbirth. Although effective treatments exist, many people and their families have difficulty coping with this embarrassing problem. Because the existing methods for assessing anorectal functions are expensive and not available in primary care clinics, the condition is often untreated, which can lead to isolation, depression or premature admission to a nursing home. This emerging technology promises to simplify diagnostic assessment and facilitate management of fecal incontinence.

Additional technologies to address concerns over the safety of angiograph contrast agents are also in development. Known as a Hemostasis Valve, the technology allows Cardiologists and Radiologists to more safely, quickly and easily perform catheter based procedures. The valves can significantly reduce bleeding. The procedure is accomplished in less time and gives the physician more control over catheter placement than valves currently available in the marketplace.

Mayo Clinic has licensed these technologies through its Office of Intellectual Property to Medspira and will receive royalties from sales. Mayo Clinic also holds an equity position in Medspira.

About Medspira

Medspira was formed by a group of private investors to bring new, clinically inspired technologies to a wider audience for the benefit of patients and physicians. Its highly focused sales model serves the market in both North America and worldwide. These devices represent the first products for the company. For more information, contact Sarah Thornton (sthornton@medspira.com).

About Mayo Clinic Office of Intellectual Property

Mayo Clinic has one of the most highly evolved intellectual property and technology commercialization efforts in academic medicine, with a 20-year history of supporting Mayo's mission.

The Office of Intellectual Property at Mayo Clinic serves as a bridge between discoveries and the marketplace. The office works with inventors and commercial industry to determine the right fit for each innovation, whether a sponsored research agreement, licensing agreement, technology-based venture, start-up company or entirely new business model. Mayo Clinic's Office of Intellectual Property has filed more than 2,400 patents resulting in over 600 active patent-licensing agreements with business partners in the biomedical and manufacturing industries.

SOURCE Medspira


'/>"/>
SOURCE Medspira
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Albireo Announces Positive Clinical Data on A3309 in Patients with Chronic Idiopathic Constipation
2. College Opens Free Dental Hygiene Clinic To Serve The Public
3. News brief: Adverse symptom reporting by patients vs. clinicians
4. Tulane Cancer Center to begin novel clinical trial for late-stage prostate cancer drug
5. Ziosoft Will Showcase New Clinical Functionality and Workflow Optimization Tools for Its Advanced 3D Thin-Client Software at RSNA 2009
6. Department of Health Updates H1N1 Vaccine Distribution Effort, Reminds At-Risk Residents of Upcoming Vaccination Clinics
7. American Heart Association Late Breaking Clinical Trial Report: In Patients on Statins, Raising Good Cholesterol with Niacin, but not Reducing Bad Cholesterol with Ezetimibe, Decreases Plaque Build-Up
8. First Global Atrial Fibrillation Registry, RecordAF, Shows Rhythm-Control Strategy With Current Therapies Achieves Improved Disease Control but not Clinical Outcomes
9. American Heart Association Late Breaking Clinical Trial Report: Tests Predict Which Patients Are Resistant to Anti-Clotting Therapy During Angioplasty, Stenting
10. Multiple Health Conditions Discovered During Free Clinic for Uninsured People in New Orleans
11. November 2009 Mayo Clinic Health Letter Highlights Self-Care Tips for Hemorrhoids, Interactive Video Games Improve Health and Heart Failure Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health ... of their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards ... at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Any dentist who has made ... the current process. Many of them do not even offer ... difficulties and high laboratory costs involved. And those who ARE ... at such a high cost that the majority of today,s ... Dr. Parsa Zadeh , founder of Dental Evolutions Inc. ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
Breaking Medicine Technology: